XRTEF yields 123.46% · PFE yields 6.13%● Live data
📍 XRTEF pulled ahead of the other in Year 1
Combined, XRTEF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of XRTEF + PFE for your $10,000?
Xeros Technology Group plc, together with its subsidiaries, develops and commercializes polymer-based technologies in Europe, North America, and internationally. The company also engages in the research, development, and commercialization of polymer technology alternatives to traditional aqueous based technologies. Its technologies reduced water usage, lower energy consumption and less microplastic pollution in the fields of fabric and garment manufacture, and industrial and domestic laundry. The company offers XOrbs, a reusable polymer technology that replace pumice and reduce water, energy, and chemistry, as well as wash and care for clothes in domestic and commercial washing machines; XDrum, a technology collects the XOrbs back into their storage system; and XFilter, a washing machine filtration technology, which prevents harmful microfibers pollution from being released into the rivers and oceans. The company was formerly known as Hamsard 3323 Limited and changed its name to Xeros Technology Group plc in March 2014. Xeros Technology Group plc was incorporated in 2013 and is based in Rotherham, the United Kingdom.
Full XRTEF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.